nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP3A4—bone cancer	0.324	1	CbGaD
Phenytoin—SLCO1C1—Methotrexate—bone cancer	0.115	0.269	CbGbCtD
Phenytoin—ABCC2—Carboplatin—bone cancer	0.0595	0.138	CbGbCtD
Phenytoin—ABCC2—Cisplatin—bone cancer	0.0508	0.118	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—bone cancer	0.0341	0.0793	CbGbCtD
Phenytoin—ABCC2—Methotrexate—bone cancer	0.033	0.0768	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—bone cancer	0.0323	0.0752	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—bone cancer	0.0217	0.0504	CbGbCtD
Phenytoin—ALB—Methotrexate—bone cancer	0.0206	0.0479	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—bone cancer	0.0171	0.0398	CbGbCtD
Phenytoin—ABCB1—Cisplatin—bone cancer	0.0166	0.0386	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—bone cancer	0.0111	0.0259	CbGbCtD
Phenytoin—ABCB1—Methotrexate—bone cancer	0.0108	0.025	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—bone cancer	0.00665	0.0155	CbGbCtD
Phenytoin—Fosphenytoin—CYP3A4—bone cancer	0.000536	0.143	CrCbGaD
Phenytoin—Oxaprozin—PTGS2—bone cancer	0.000505	0.135	CrCbGaD
Phenytoin—Phenprocoumon—CYP3A4—bone cancer	0.000367	0.0983	CrCbGaD
Phenytoin—Primidone—CYP3A4—bone cancer	0.000359	0.0962	CrCbGaD
Phenytoin—Phenylbutazone—CYP3A4—bone cancer	0.000341	0.0912	CrCbGaD
Phenytoin—Phenylbutazone—PTGS2—bone cancer	0.000334	0.0893	CrCbGaD
Phenytoin—Warfarin—CYP3A4—bone cancer	0.000326	0.0872	CrCbGaD
Phenytoin—Modafinil—CYP3A4—bone cancer	0.000267	0.0714	CrCbGaD
Phenytoin—Carbamazepine—CYP3A4—bone cancer	0.000244	0.0652	CrCbGaD
Phenytoin—Benzphetamine—CYP3A4—bone cancer	0.000231	0.0619	CrCbGaD
Phenytoin—Phenobarbital—CYP3A4—bone cancer	0.000227	0.0607	CrCbGaD
Phenytoin—Liver function test abnormal—Doxorubicin—bone cancer	0.000198	0.00108	CcSEcCtD
Phenytoin—Dyspnoea—Cisplatin—bone cancer	0.000197	0.00108	CcSEcCtD
Phenytoin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000195	0.00107	CcSEcCtD
Phenytoin—Abdominal pain upper—Doxorubicin—bone cancer	0.000195	0.00107	CcSEcCtD
Phenytoin—Photosensitivity reaction—Methotrexate—bone cancer	0.000195	0.00106	CcSEcCtD
Phenytoin—Hypokalaemia—Doxorubicin—bone cancer	0.000195	0.00106	CcSEcCtD
Phenytoin—Breast disorder—Doxorubicin—bone cancer	0.000193	0.00105	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000193	0.00105	CcSEcCtD
Phenytoin—Decreased appetite—Cisplatin—bone cancer	0.000192	0.00105	CcSEcCtD
Phenytoin—Bronchitis—Epirubicin—bone cancer	0.000192	0.00105	CcSEcCtD
Phenytoin—Pneumonia—Methotrexate—bone cancer	0.000192	0.00104	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000191	0.00104	CcSEcCtD
Phenytoin—CYP11B1—Biological oxidations—GSTP1—bone cancer	0.000191	0.00319	CbGpPWpGaD
Phenytoin—Drowsiness—Methotrexate—bone cancer	0.00019	0.00104	CcSEcCtD
Phenytoin—Pancytopenia—Epirubicin—bone cancer	0.00019	0.00104	CcSEcCtD
Phenytoin—Gastritis—Doxorubicin—bone cancer	0.000189	0.00103	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000189	0.00103	CcSEcCtD
Phenytoin—Muscular weakness—Doxorubicin—bone cancer	0.000189	0.00103	CcSEcCtD
Phenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000189	0.00315	CbGpPWpGaD
Phenytoin—CYP11B1—Metapathway biotransformation—GSTP1—bone cancer	0.000188	0.00314	CbGpPWpGaD
Phenytoin—Renal failure—Methotrexate—bone cancer	0.000187	0.00102	CcSEcCtD
Phenytoin—Dysuria—Epirubicin—bone cancer	0.000187	0.00102	CcSEcCtD
Phenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000186	0.00311	CbGpPWpGaD
Phenytoin—Conjunctivitis—Methotrexate—bone cancer	0.000185	0.00101	CcSEcCtD
Phenytoin—Dysphagia—Doxorubicin—bone cancer	0.000185	0.00101	CcSEcCtD
Phenytoin—Asthma—Doxorubicin—bone cancer	0.000185	0.00101	CcSEcCtD
Phenytoin—Influenza—Doxorubicin—bone cancer	0.000185	0.00101	CcSEcCtD
Phenytoin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000184	0.00308	CbGpPWpGaD
Phenytoin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000184	0.00307	CbGpPWpGaD
Phenytoin—Eosinophilia—Doxorubicin—bone cancer	0.000183	0.000999	CcSEcCtD
Phenytoin—Sweating—Methotrexate—bone cancer	0.000183	0.000996	CcSEcCtD
Phenytoin—Photosensitivity reaction—Epirubicin—bone cancer	0.000182	0.000995	CcSEcCtD
Phenytoin—Feeling abnormal—Cisplatin—bone cancer	0.000182	0.000995	CcSEcCtD
Phenytoin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000182	0.00304	CbGpPWpGaD
Phenytoin—Weight decreased—Epirubicin—bone cancer	0.000181	0.000986	CcSEcCtD
Phenytoin—Hyperglycaemia—Epirubicin—bone cancer	0.00018	0.000984	CcSEcCtD
Phenytoin—SCN8A—L1CAM interactions—EGFR—bone cancer	0.00018	0.00301	CbGpPWpGaD
Phenytoin—Hepatobiliary disease—Methotrexate—bone cancer	0.00018	0.000983	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—bone cancer	0.00018	0.00098	CcSEcCtD
Phenytoin—Pneumonia—Epirubicin—bone cancer	0.000179	0.000978	CcSEcCtD
Phenytoin—Drowsiness—Epirubicin—bone cancer	0.000178	0.000972	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—bone cancer	0.000178	0.00097	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—bone cancer	0.000178	0.000969	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000177	0.000964	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—bone cancer	0.000176	0.000958	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—bone cancer	0.000175	0.000956	CcSEcCtD
Phenytoin—Body temperature increased—Cisplatin—bone cancer	0.000175	0.000954	CcSEcCtD
Phenytoin—ALB—Folate Metabolism—DHFR—bone cancer	0.000174	0.0029	CbGpPWpGaD
Phenytoin—Conjunctivitis—Epirubicin—bone cancer	0.000173	0.000945	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—bone cancer	0.000173	0.000943	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—bone cancer	0.000172	0.000937	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—bone cancer	0.000171	0.000933	CcSEcCtD
Phenytoin—Sweating—Epirubicin—bone cancer	0.000171	0.000932	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—bone cancer	0.00017	0.000926	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000169	0.000921	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—bone cancer	0.000169	0.000919	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—bone cancer	0.000168	0.000917	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—bone cancer	0.000167	0.000913	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—bone cancer	0.000167	0.000912	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—bone cancer	0.000167	0.00091	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—bone cancer	0.000166	0.000907	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—bone cancer	0.000166	0.000905	CcSEcCtD
Phenytoin—CYP2C18—Biological oxidations—CYP3A4—bone cancer	0.000165	0.00276	CbGpPWpGaD
Phenytoin—Drowsiness—Doxorubicin—bone cancer	0.000165	0.0009	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000163	0.000892	CcSEcCtD
Phenytoin—Hypersensitivity—Cisplatin—bone cancer	0.000163	0.00089	CcSEcCtD
Phenytoin—CYP2C18—Metapathway biotransformation—CYP3A4—bone cancer	0.000163	0.00272	CbGpPWpGaD
Phenytoin—Bradycardia—Epirubicin—bone cancer	0.000163	0.000888	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—bone cancer	0.000162	0.000884	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—bone cancer	0.000162	0.000882	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—bone cancer	0.000161	0.000877	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—bone cancer	0.00016	0.000875	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—bone cancer	0.00016	0.000874	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—bone cancer	0.00016	0.000873	CcSEcCtD
Phenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00016	0.00267	CbGpPWpGaD
Phenytoin—Tinnitus—Methotrexate—bone cancer	0.000159	0.00087	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—bone cancer	0.000159	0.000868	CcSEcCtD
Phenytoin—Asthenia—Cisplatin—bone cancer	0.000159	0.000866	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—bone cancer	0.000159	0.000866	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—bone cancer	0.000158	0.000862	CcSEcCtD
Phenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000158	0.00263	CbGpPWpGaD
Phenytoin—Connective tissue disorder—Epirubicin—bone cancer	0.000157	0.000858	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000156	0.000851	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—bone cancer	0.000156	0.000848	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—bone cancer	0.000155	0.000844	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—bone cancer	0.000154	0.000842	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—bone cancer	0.000154	0.000839	CcSEcCtD
Phenytoin—Chills—Methotrexate—bone cancer	0.000153	0.000837	CcSEcCtD
Phenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000153	0.00255	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—SPARC—bone cancer	0.000152	0.00254	CbGpPWpGaD
Phenytoin—Diarrhoea—Cisplatin—bone cancer	0.000151	0.000826	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—bone cancer	0.000151	0.000825	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—bone cancer	0.000151	0.000822	CcSEcCtD
Phenytoin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00015	0.00249	CbGpPWpGaD
Phenytoin—Tinnitus—Epirubicin—bone cancer	0.000149	0.000814	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—bone cancer	0.000149	0.000812	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—bone cancer	0.000148	0.00081	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—bone cancer	0.000148	0.000808	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—bone cancer	0.000147	0.000803	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—bone cancer	0.000147	0.000801	CcSEcCtD
Phenytoin—SCN9A—L1CAM interactions—EGFR—bone cancer	0.000146	0.00243	CbGpPWpGaD
Phenytoin—Dysgeusia—Methotrexate—bone cancer	0.000146	0.000795	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—bone cancer	0.000145	0.000794	CcSEcCtD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000145	0.00242	CbGpPWpGaD
Phenytoin—Immune system disorder—Epirubicin—bone cancer	0.000145	0.000788	CcSEcCtD
Phenytoin—Back pain—Methotrexate—bone cancer	0.000144	0.000785	CcSEcCtD
Phenytoin—Chills—Epirubicin—bone cancer	0.000144	0.000783	CcSEcCtD
Phenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000143	0.00238	CbGpPWpGaD
Phenytoin—CYP2C18—Biological oxidations—GSTP1—bone cancer	0.000141	0.00236	CbGpPWpGaD
Phenytoin—Vomiting—Cisplatin—bone cancer	0.000141	0.000768	CcSEcCtD
Phenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000141	0.00235	CbGpPWpGaD
Phenytoin—Erythema multiforme—Doxorubicin—bone cancer	0.00014	0.000764	CcSEcCtD
Phenytoin—Rash—Cisplatin—bone cancer	0.00014	0.000761	CcSEcCtD
Phenytoin—SCN3A—L1CAM interactions—EGFR—bone cancer	0.000139	0.00233	CbGpPWpGaD
Phenytoin—Dermatitis—Cisplatin—bone cancer	0.000139	0.000761	CcSEcCtD
Phenytoin—CYP2C18—Metapathway biotransformation—GSTP1—bone cancer	0.000139	0.00233	CbGpPWpGaD
Phenytoin—Ill-defined disorder—Methotrexate—bone cancer	0.000138	0.000753	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—bone cancer	0.000138	0.000753	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—bone cancer	0.000138	0.00075	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—bone cancer	0.000137	0.000749	CcSEcCtD
Phenytoin—Tension—Epirubicin—bone cancer	0.000137	0.000746	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—bone cancer	0.000136	0.000744	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—bone cancer	0.000135	0.000738	CcSEcCtD
Phenytoin—Back pain—Epirubicin—bone cancer	0.000135	0.000735	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—MET—bone cancer	0.000134	0.00224	CbGpPWpGaD
Phenytoin—Malaise—Methotrexate—bone cancer	0.000134	0.000732	CcSEcCtD
Phenytoin—SCN4A—L1CAM interactions—EGFR—bone cancer	0.000134	0.00224	CbGpPWpGaD
Phenytoin—SCN2A—L1CAM interactions—EGFR—bone cancer	0.000134	0.00224	CbGpPWpGaD
Phenytoin—Muscle spasms—Epirubicin—bone cancer	0.000134	0.00073	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—NDUFA12—bone cancer	0.000134	0.00223	CbGpPWpGaD
Phenytoin—Immune system disorder—Doxorubicin—bone cancer	0.000134	0.000729	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—bone cancer	0.000134	0.000729	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—bone cancer	0.000133	0.000727	CcSEcCtD
Phenytoin—Chills—Doxorubicin—bone cancer	0.000133	0.000725	CcSEcCtD
Phenytoin—Nausea—Cisplatin—bone cancer	0.000131	0.000717	CcSEcCtD
Phenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00013	0.00217	CbGpPWpGaD
Phenytoin—Cough—Methotrexate—bone cancer	0.00013	0.000708	CcSEcCtD
Phenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00013	0.00216	CbGpPWpGaD
Phenytoin—Ill-defined disorder—Epirubicin—bone cancer	0.000129	0.000705	CcSEcCtD
Phenytoin—SCN1A—L1CAM interactions—EGFR—bone cancer	0.000129	0.00216	CbGpPWpGaD
Phenytoin—Convulsion—Methotrexate—bone cancer	0.000129	0.000703	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—bone cancer	0.000129	0.000702	CcSEcCtD
Phenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000128	0.00214	CbGpPWpGaD
Phenytoin—Agitation—Epirubicin—bone cancer	0.000128	0.000698	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—bone cancer	0.000127	0.000693	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—bone cancer	0.000127	0.000691	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—bone cancer	0.000127	0.000691	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—bone cancer	0.000127	0.000691	CcSEcCtD
Phenytoin—Tension—Doxorubicin—bone cancer	0.000126	0.00069	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—bone cancer	0.000126	0.000688	CcSEcCtD
Phenytoin—Malaise—Epirubicin—bone cancer	0.000126	0.000685	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—bone cancer	0.000125	0.000683	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—bone cancer	0.000125	0.000683	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—bone cancer	0.000125	0.000683	CcSEcCtD
Phenytoin—Syncope—Epirubicin—bone cancer	0.000125	0.000681	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—bone cancer	0.000125	0.00068	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—bone cancer	0.000125	0.00068	CcSEcCtD
Phenytoin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000124	0.00207	CbGpPWpGaD
Phenytoin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000124	0.00207	CbGpPWpGaD
Phenytoin—Muscle spasms—Doxorubicin—bone cancer	0.000124	0.000676	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—bone cancer	0.000123	0.000671	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—bone cancer	0.000122	0.000668	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—bone cancer	0.000122	0.000668	CcSEcCtD
Phenytoin—Cough—Epirubicin—bone cancer	0.000122	0.000663	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—bone cancer	0.000121	0.000663	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—bone cancer	0.000121	0.000658	CcSEcCtD
Phenytoin—Infection—Methotrexate—bone cancer	0.000121	0.000658	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—bone cancer	0.00012	0.000656	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—bone cancer	0.00012	0.000652	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—bone cancer	0.000119	0.00065	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—bone cancer	0.000119	0.00065	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—bone cancer	0.000119	0.000649	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—bone cancer	0.000119	0.000647	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—bone cancer	0.000119	0.000647	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—bone cancer	0.000119	0.000647	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—bone cancer	0.000118	0.000646	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—bone cancer	0.000117	0.000641	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—bone cancer	0.000117	0.000639	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—bone cancer	0.000116	0.000634	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—bone cancer	0.000116	0.000633	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—bone cancer	0.000116	0.000632	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—bone cancer	0.000116	0.000632	CcSEcCtD
Phenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000116	0.00193	CbGpPWpGaD
Phenytoin—Syncope—Doxorubicin—bone cancer	0.000116	0.00063	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—bone cancer	0.000115	0.000629	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—bone cancer	0.000115	0.000625	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—bone cancer	0.000114	0.000621	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—bone cancer	0.000114	0.00062	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—bone cancer	0.000113	0.000619	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—bone cancer	0.000113	0.000618	CcSEcCtD
Phenytoin—Infection—Epirubicin—bone cancer	0.000113	0.000616	CcSEcCtD
Phenytoin—Cough—Doxorubicin—bone cancer	0.000112	0.000613	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—MMP2—bone cancer	0.000112	0.00187	CbGpPWpGaD
Phenytoin—Shock—Epirubicin—bone cancer	0.000112	0.00061	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—bone cancer	0.000112	0.000609	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—bone cancer	0.000111	0.000608	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—bone cancer	0.000111	0.000607	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—bone cancer	0.000111	0.000607	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—bone cancer	0.000111	0.000605	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—NT5C3A—bone cancer	0.000111	0.00185	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000111	0.000604	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—bone cancer	0.00011	0.000599	CcSEcCtD
Phenytoin—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.00011	0.00183	CbGpPWpGaD
Phenytoin—Insomnia—Methotrexate—bone cancer	0.00011	0.000599	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—bone cancer	0.00011	0.000598	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—bone cancer	0.00011	0.000598	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—bone cancer	0.00011	0.000598	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—bone cancer	0.000109	0.000595	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—MET—bone cancer	0.000109	0.00181	CbGpPWpGaD
Phenytoin—Discomfort—Doxorubicin—bone cancer	0.000108	0.000591	CcSEcCtD
Phenytoin—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000108	0.00181	CbGpPWpGaD
Phenytoin—Anorexia—Epirubicin—bone cancer	0.000108	0.000591	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—bone cancer	0.000108	0.000591	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—bone cancer	0.000108	0.000589	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—bone cancer	0.000107	0.000585	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—bone cancer	0.000107	0.000583	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—bone cancer	0.000106	0.000579	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—bone cancer	0.000106	0.000578	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—bone cancer	0.000106	0.000576	CcSEcCtD
Phenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000105	0.00176	CbGpPWpGaD
Phenytoin—Anaphylactic shock—Doxorubicin—bone cancer	0.000105	0.000574	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000105	0.000572	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—bone cancer	0.000105	0.000571	CcSEcCtD
Phenytoin—Infection—Doxorubicin—bone cancer	0.000104	0.00057	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—MET—bone cancer	0.000104	0.00174	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000104	0.000565	CcSEcCtD
Phenytoin—Shock—Doxorubicin—bone cancer	0.000103	0.000564	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—bone cancer	0.000103	0.000563	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—bone cancer	0.000103	0.000562	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—bone cancer	0.000103	0.000561	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—bone cancer	0.000103	0.00056	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—bone cancer	0.000102	0.000557	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—bone cancer	0.000102	0.000555	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—bone cancer	0.000101	0.000553	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—bone cancer	0.000101	0.000551	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—bone cancer	0.0001	0.000547	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—bone cancer	0.0001	0.000546	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—bone cancer	0.0001	0.000546	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—MET—bone cancer	9.99e-05	0.00167	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—MET—bone cancer	9.99e-05	0.00167	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—NDUFA12—bone cancer	9.91e-05	0.00165	CbGpPWpGaD
Phenytoin—Decreased appetite—Epirubicin—bone cancer	9.88e-05	0.000539	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—bone cancer	9.83e-05	0.000536	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—bone cancer	9.81e-05	0.000535	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—bone cancer	9.8e-05	0.000535	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.77e-05	0.00163	CbGpPWpGaD
Phenytoin—Constipation—Epirubicin—bone cancer	9.72e-05	0.00053	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—bone cancer	9.65e-05	0.000526	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—MET—bone cancer	9.64e-05	0.00161	CbGpPWpGaD
Phenytoin—Body temperature increased—Methotrexate—bone cancer	9.6e-05	0.000524	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—MET—bone cancer	9.59e-05	0.0016	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—CDK4—bone cancer	9.59e-05	0.0016	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.58e-05	0.000523	CcSEcCtD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	9.55e-05	0.00159	CbGpPWpGaD
Phenytoin—Insomnia—Doxorubicin—bone cancer	9.51e-05	0.000519	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—bone cancer	9.44e-05	0.000515	CcSEcCtD
Phenytoin—CYP3A7—Biological oxidations—GSTP1—bone cancer	9.4e-05	0.00157	CbGpPWpGaD
Phenytoin—Dyspnoea—Doxorubicin—bone cancer	9.38e-05	0.000511	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—bone cancer	9.37e-05	0.000511	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—bone cancer	9.35e-05	0.00051	CcSEcCtD
Phenytoin—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	9.27e-05	0.00155	CbGpPWpGaD
Phenytoin—Dyspepsia—Doxorubicin—bone cancer	9.26e-05	0.000505	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—bone cancer	9.14e-05	0.000499	CcSEcCtD
Phenytoin—SCN5A—L1CAM interactions—EGFR—bone cancer	9.08e-05	0.00152	CbGpPWpGaD
Phenytoin—Gastrointestinal disorder—Doxorubicin—bone cancer	9.08e-05	0.000495	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—MMP2—bone cancer	9.07e-05	0.00151	CbGpPWpGaD
Phenytoin—Fatigue—Doxorubicin—bone cancer	9.07e-05	0.000495	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—bone cancer	9.03e-05	0.000493	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—bone cancer	8.99e-05	0.000491	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—bone cancer	8.98e-05	0.00049	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—bone cancer	8.95e-05	0.000488	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—bone cancer	8.71e-05	0.000475	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—MMP2—bone cancer	8.68e-05	0.00145	CbGpPWpGaD
Phenytoin—Feeling abnormal—Doxorubicin—bone cancer	8.67e-05	0.000473	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—bone cancer	8.59e-05	0.000469	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.44e-05	0.00141	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—MMP9—bone cancer	8.43e-05	0.00141	CbGpPWpGaD
Phenytoin—Hypersensitivity—Epirubicin—bone cancer	8.37e-05	0.000457	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—bone cancer	8.35e-05	0.000456	CcSEcCtD
Phenytoin—SCN2A—Axon guidance—MMP2—bone cancer	8.34e-05	0.00139	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—MMP2—bone cancer	8.34e-05	0.00139	CbGpPWpGaD
Phenytoin—Body temperature increased—Doxorubicin—bone cancer	8.31e-05	0.000454	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—bone cancer	8.31e-05	0.000453	CcSEcCtD
Phenytoin—CYP2C18—Metabolism—NT5C3A—bone cancer	8.21e-05	0.00137	CbGpPWpGaD
Phenytoin—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	8.19e-05	0.00137	CbGpPWpGaD
Phenytoin—Asthenia—Epirubicin—bone cancer	8.15e-05	0.000445	CcSEcCtD
Phenytoin—CYP2B6—Biological oxidations—CYP3A4—bone cancer	8.13e-05	0.00136	CbGpPWpGaD
Phenytoin—Pruritus—Epirubicin—bone cancer	8.04e-05	0.000439	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—MMP2—bone cancer	8.04e-05	0.00134	CbGpPWpGaD
Phenytoin—Dizziness—Methotrexate—bone cancer	8.03e-05	0.000438	CcSEcCtD
Phenytoin—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	8.01e-05	0.00134	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—MMP2—bone cancer	8e-05	0.00134	CbGpPWpGaD
Phenytoin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	7.94e-05	0.00133	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	7.83e-05	0.00131	CbGpPWpGaD
Phenytoin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	7.83e-05	0.00131	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.82e-05	0.0013	CbGpPWpGaD
Phenytoin—Diarrhoea—Epirubicin—bone cancer	7.78e-05	0.000424	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—CDK4—bone cancer	7.76e-05	0.00129	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—MET—bone cancer	7.76e-05	0.00129	CbGpPWpGaD
Phenytoin—Hypersensitivity—Doxorubicin—bone cancer	7.75e-05	0.000423	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—bone cancer	7.72e-05	0.000421	CcSEcCtD
Phenytoin—Rash—Methotrexate—bone cancer	7.66e-05	0.000418	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—bone cancer	7.65e-05	0.000417	CcSEcCtD
Phenytoin—Headache—Methotrexate—bone cancer	7.61e-05	0.000415	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—bone cancer	7.55e-05	0.000412	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—bone cancer	7.52e-05	0.00041	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—bone cancer	7.44e-05	0.000406	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—MET—bone cancer	7.42e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CDK4—bone cancer	7.42e-05	0.00124	CbGpPWpGaD
Phenytoin—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	7.31e-05	0.00122	CbGpPWpGaD
Phenytoin—Vomiting—Epirubicin—bone cancer	7.23e-05	0.000394	CcSEcCtD
Phenytoin—Nausea—Methotrexate—bone cancer	7.21e-05	0.000394	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—bone cancer	7.2e-05	0.000393	CcSEcCtD
Phenytoin—Rash—Epirubicin—bone cancer	7.17e-05	0.000391	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—bone cancer	7.16e-05	0.000391	CcSEcCtD
Phenytoin—SCN4A—Developmental Biology—CDK4—bone cancer	7.13e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—MET—bone cancer	7.13e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CDK4—bone cancer	7.13e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—MET—bone cancer	7.13e-05	0.00119	CbGpPWpGaD
Phenytoin—Headache—Epirubicin—bone cancer	7.12e-05	0.000388	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—bone cancer	6.95e-05	0.000379	CcSEcCtD
Phenytoin—CYP2B6—Biological oxidations—GSTP1—bone cancer	6.95e-05	0.00116	CbGpPWpGaD
Phenytoin—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.88e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—MET—bone cancer	6.88e-05	0.00115	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CDK4—bone cancer	6.88e-05	0.00115	CbGpPWpGaD
Phenytoin—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.85e-05	0.00114	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—MMP9—bone cancer	6.82e-05	0.00114	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—EGFR—bone cancer	6.81e-05	0.00114	CbGpPWpGaD
Phenytoin—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.79e-05	0.00113	CbGpPWpGaD
Phenytoin—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.78e-05	0.00113	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—MET—bone cancer	6.77e-05	0.00113	CbGpPWpGaD
Phenytoin—Nausea—Epirubicin—bone cancer	6.75e-05	0.000368	CcSEcCtD
Phenytoin—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	6.75e-05	0.00113	CbGpPWpGaD
Phenytoin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.7e-05	0.00112	CbGpPWpGaD
Phenytoin—Vomiting—Doxorubicin—bone cancer	6.69e-05	0.000365	CcSEcCtD
Phenytoin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.67e-05	0.00111	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6.65e-05	0.00111	CbGpPWpGaD
Phenytoin—Rash—Doxorubicin—bone cancer	6.63e-05	0.000362	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—bone cancer	6.62e-05	0.000361	CcSEcCtD
Phenytoin—Headache—Doxorubicin—bone cancer	6.59e-05	0.000359	CcSEcCtD
Phenytoin—CYP3A7—Metabolism—NDUFA12—bone cancer	6.59e-05	0.0011	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—MMP9—bone cancer	6.52e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—MMP2—bone cancer	6.47e-05	0.00108	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—MMP9—bone cancer	6.26e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—MMP9—bone cancer	6.26e-05	0.00105	CbGpPWpGaD
Phenytoin—Nausea—Doxorubicin—bone cancer	6.25e-05	0.000341	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—MMP2—bone cancer	6.19e-05	0.00103	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	6.17e-05	0.00103	CbGpPWpGaD
Phenytoin—CYP2C19—Biological oxidations—CYP3A4—bone cancer	6.14e-05	0.00102	CbGpPWpGaD
Phenytoin—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.06e-05	0.00101	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.05e-05	0.00101	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—MMP9—bone cancer	6.04e-05	0.00101	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—MMP9—bone cancer	6.02e-05	0.001	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—MMP2—bone cancer	5.95e-05	0.000992	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—MMP2—bone cancer	5.95e-05	0.000992	CbGpPWpGaD
Phenytoin—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.88e-05	0.000982	CbGpPWpGaD
Phenytoin—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.8e-05	0.000968	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—MMP2—bone cancer	5.74e-05	0.000957	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—MMP2—bone cancer	5.65e-05	0.000943	CbGpPWpGaD
Phenytoin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.6e-05	0.000934	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	5.6e-05	0.000934	CbGpPWpGaD
Phenytoin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	5.52e-05	0.000921	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	5.51e-05	0.00092	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—EGFR—bone cancer	5.51e-05	0.000919	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NT5C3A—bone cancer	5.46e-05	0.00091	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	5.44e-05	0.000907	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—EGFR—bone cancer	5.27e-05	0.000879	CbGpPWpGaD
Phenytoin—CYP2C19—Biological oxidations—GSTP1—bone cancer	5.25e-05	0.000876	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.24e-05	0.000875	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	5.18e-05	0.000864	CbGpPWpGaD
Phenytoin—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.18e-05	0.000864	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.15e-05	0.00086	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—EGFR—bone cancer	5.06e-05	0.000845	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—EGFR—bone cancer	5.06e-05	0.000845	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—EGFR—bone cancer	4.88e-05	0.000815	CbGpPWpGaD
Phenytoin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.87e-05	0.000813	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NDUFA12—bone cancer	4.87e-05	0.000813	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—MMP9—bone cancer	4.86e-05	0.000812	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—EGFR—bone cancer	4.86e-05	0.000811	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ENO2—bone cancer	4.86e-05	0.00081	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CDK4—bone cancer	4.83e-05	0.000807	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MET—bone cancer	4.83e-05	0.000807	CbGpPWpGaD
Phenytoin—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.79e-05	0.000799	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NDUFA12—bone cancer	4.76e-05	0.000794	CbGpPWpGaD
Phenytoin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.72e-05	0.000788	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—MMP9—bone cancer	4.65e-05	0.000776	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.61e-05	0.000769	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.59e-05	0.000767	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.53e-05	0.000755	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—DHFR—bone cancer	4.51e-05	0.000752	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—MMP9—bone cancer	4.47e-05	0.000746	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—MMP9—bone cancer	4.47e-05	0.000746	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—MMP9—bone cancer	4.31e-05	0.000719	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—MMP9—bone cancer	4.25e-05	0.000709	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—GNA11—bone cancer	4.21e-05	0.000703	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NDUFA12—bone cancer	4.12e-05	0.000688	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NDUFA12—bone cancer	4.1e-05	0.000684	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NT5C3A—bone cancer	4.04e-05	0.000673	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MMP2—bone cancer	4.03e-05	0.000673	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.97e-05	0.000662	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NT5C3A—bone cancer	3.94e-05	0.000658	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—EGFR—bone cancer	3.93e-05	0.000656	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—bone cancer	3.88e-05	0.000648	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CYP3A4—bone cancer	3.82e-05	0.000637	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.8e-05	0.000634	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—EGFR—bone cancer	3.76e-05	0.000627	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NDUFA12—bone cancer	3.68e-05	0.000614	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—EGFR—bone cancer	3.61e-05	0.000603	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—EGFR—bone cancer	3.61e-05	0.000603	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ENO2—bone cancer	3.6e-05	0.0006	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NDUFA12—bone cancer	3.59e-05	0.000599	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—EGFR—bone cancer	3.48e-05	0.000581	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SPARC—bone cancer	3.48e-05	0.000581	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—EGFR—bone cancer	3.43e-05	0.000573	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.42e-05	0.00057	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NT5C3A—bone cancer	3.42e-05	0.00057	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NT5C3A—bone cancer	3.4e-05	0.000567	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NDUFA12—bone cancer	3.36e-05	0.00056	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—DHFR—bone cancer	3.34e-05	0.000557	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—GSTP1—bone cancer	3.27e-05	0.000545	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—GNA11—bone cancer	3.18e-05	0.000531	CbGpPWpGaD
Phenytoin—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.16e-05	0.000527	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GNA11—bone cancer	3.12e-05	0.00052	CbGpPWpGaD
Phenytoin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.11e-05	0.00052	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NT5C3A—bone cancer	3.05e-05	0.000509	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MMP9—bone cancer	3.03e-05	0.000506	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NT5C3A—bone cancer	2.98e-05	0.000497	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL3—bone cancer	2.89e-05	0.000481	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CYP3A4—bone cancer	2.83e-05	0.000472	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NT5C3A—bone cancer	2.78e-05	0.000464	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.53e-05	0.000423	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EGFR—bone cancer	2.45e-05	0.000409	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.44e-05	0.000407	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GSTP1—bone cancer	2.42e-05	0.000403	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ENO2—bone cancer	2.39e-05	0.000399	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—DHFR—bone cancer	2.22e-05	0.00037	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NDUFA12—bone cancer	2.21e-05	0.000369	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.2e-05	0.000367	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GNA11—bone cancer	2.07e-05	0.000346	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PLAU—bone cancer	1.89e-05	0.000316	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP3A4—bone cancer	1.88e-05	0.000313	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NT5C3A—bone cancer	1.83e-05	0.000306	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO2—bone cancer	1.77e-05	0.000295	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.73e-05	0.000289	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO2—bone cancer	1.73e-05	0.000288	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—bone cancer	1.69e-05	0.000282	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—DHFR—bone cancer	1.64e-05	0.000274	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTP1—bone cancer	1.61e-05	0.000268	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—DHFR—bone cancer	1.6e-05	0.000267	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GNA11—bone cancer	1.53e-05	0.000256	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GNA11—bone cancer	1.5e-05	0.00025	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO2—bone cancer	1.5e-05	0.00025	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO2—bone cancer	1.49e-05	0.000248	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.45e-05	0.000242	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP3A4—bone cancer	1.39e-05	0.000232	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—DHFR—bone cancer	1.39e-05	0.000232	CbGpPWpGaD
Phenytoin—ALB—Metabolism—DHFR—bone cancer	1.38e-05	0.00023	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.36e-05	0.000227	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO2—bone cancer	1.34e-05	0.000223	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—bone cancer	1.3e-05	0.000218	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GNA11—bone cancer	1.3e-05	0.000217	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GNA11—bone cancer	1.29e-05	0.000215	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—bone cancer	1.25e-05	0.000209	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—DHFR—bone cancer	1.24e-05	0.000207	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO2—bone cancer	1.22e-05	0.000203	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—DHFR—bone cancer	1.21e-05	0.000202	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTP1—bone cancer	1.19e-05	0.000198	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP3A4—bone cancer	1.18e-05	0.000196	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.17e-05	0.000195	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP3A4—bone cancer	1.17e-05	0.000195	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.16e-05	0.000194	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTP1—bone cancer	1.16e-05	0.000194	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GNA11—bone cancer	1.16e-05	0.000193	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GNA11—bone cancer	1.13e-05	0.000189	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—DHFR—bone cancer	1.13e-05	0.000189	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GNA11—bone cancer	1.06e-05	0.000176	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000175	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.04e-05	0.000174	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP3A4—bone cancer	1.02e-05	0.000171	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTP1—bone cancer	1.01e-05	0.000168	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTP1—bone cancer	1e-05	0.000167	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP3A4—bone cancer	9.57e-06	0.00016	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.53e-06	0.000159	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTP1—bone cancer	8.98e-06	0.00015	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTP1—bone cancer	8.77e-06	0.000146	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—bone cancer	8.33e-06	0.000139	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTP1—bone cancer	8.19e-06	0.000137	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—bone cancer	8.03e-06	0.000134	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—bone cancer	7.61e-06	0.000127	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—DHFR—bone cancer	7.45e-06	0.000124	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GNA11—bone cancer	6.96e-06	0.000116	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—bone cancer	6.16e-06	0.000103	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—bone cancer	6.02e-06	0.0001	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTP1—bone cancer	5.4e-06	9.01e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—bone cancer	5.21e-06	8.7e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—bone cancer	5.18e-06	8.65e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—bone cancer	4.65e-06	7.76e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—bone cancer	4.54e-06	7.58e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—bone cancer	4.24e-06	7.08e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—bone cancer	2.8e-06	4.67e-05	CbGpPWpGaD
